Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

STAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costs

Analysts say private deals involve drugmakers agreeing to lower prices in Medicaid, where prices are low, in return for no price cuts in Medicare.

STAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costs

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Read the original at statnews.com →

More in Health & Medicine

More from Wednesday 2 September →